40
  • GenomeDx Information for Life

    1,660 views 4 years ago
    GenomeDx Biosciences is focused on transforming cancer patient care by putting usable genomic information in the hands of patients and their physicians. GenomeDx is developing and commercializing Decipher®, a highly validated genomic test for predicting metastatic disease in men with prostate cancer. In partnership with leading medical centers, the company has assembled the largest genomic catalogue of prostate cancer tumors in the world, representing billions of data points and more than 20 years of prostate cancer research expertise. Using advanced cloud-based bioinformatics, GenomeDx mines the genomic data to develop proprietary tests that address key clinical questions in cancer patient management. GenomeDx has partnered to share genomic data with leading clinician-scientists worldwide to collaboratively enrich the knowledge and understanding of urologic cancers for the goal of improving global cancer patient care. GenomeDx is based in San Diego, California and Vancouver, British Columbia. Show less
    Read more
  • GenomeDx Biosciences Play all

    The GenomeDx mission is to transform patient management by putting usable genomic information in the hands of physicians and patients.
    This item has been hidden
  • Decipher® Test Play all

    This item has been hidden
  • UroSketch 3D - Explore the Prostate Play all

    This item has been hidden
to add this to Watch Later

Add to

Loading playlists...